Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Bristol-Myers Squibb patents TYK2 inhibitors

June 8, 2017

BAMBI inhibition is beneficial in autoimmune diseases

May 31, 2017

FDA approves Kevzara for rheumatoid arthritis

May 23, 2017

Emmyon patents new furostan-3-ol derivatives

May 23, 2017

ALX-1141 to enter clinical development for the treatment of osteoarthritis

May 23, 2017

Articular cartilage product granted positive opinion from CHMP for European approval

May 22, 2017

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

May 22, 2017

Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee

May 19, 2017

Development of cell-mediated gene therapy Invossa updated at ASCGT

May 16, 2017

Cytokinetics' CK-2127107 named FDA orphan drug for SMA

May 16, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...